XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6

December 1, 2021

XNK Therapeutics AB’s CEO, Johan Liwing, will present at the ABGSC Private Companies event on December 6. The presentation starts at 09:30CET and will be livestreamed via https://www.introduce.se.

The presentation will be held in English and will also be available on XNK’s website www.xnktherapeutics.com shortly thereafter.

For more information, please contact:

Johan Liwing, CEO, XNK Therapeutics

Tel: +46 706 70 36 75

E-mail: johan.liwing@xnktherapeutics.com